The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
Endoscopic vessel harvesting (EVH) is a surgical technique that is used for patients with coronary artery disease. Its is recommended as a bypass to reroute blood around blocked arteries to restore and improve blood flow and oxygen to the heart. To create the bypass graft healthy blood vessels are harvested from another part of the body, often from the patient’s leg or arm.
The key factors driving the growth of this market include the increasing prevalence of cardiovascular diseases, growing preference for minimally invasive harvesting owing to advantages it offers over conventional methods, and rising geriatric population. However, the availability of alternative treatment methods for CADs and poor reimbursement scenario for EVH may hinder the growth of this market to a certain extent.
Scope of the Report
Endoscopic vessel harvesting devices are used to obtain one or more healthy vessels from the patient’s leg or arm to use as conduits to bypass obstructed blood vessels in the cardiac or peripheral region.
In the report, a detailed analysis of the Infectious disease diagnostics market is provided. The market is evaluated by collating revenues generated across segments, categorized by product, usability, vessel type, application, and geography.
Key Market Trends
Coronary Artery Disease segment is expected to cover a large share of the market
Coronary artery disease (CAD) is the leading cause of death and disability and has a major impact on developing and developed nations. CAD is the most common serious chronic illness that evolves over the years but remains undiagnosed until it presents with life-threatening situations. It is the most common preventable non-communicable disease.
According to a report by Gregory A. Roth et al. published in Journal of the American College of Cardiology 2017, there were 12.59 million deaths due to Cardiovascular disease (CVD) in 1990, increasing to 17.92 million deaths in 2015, with CAD being the leading cause of CVD health lost globally.
As a result of the increasing number of CAD cases, the demand for treatment involving Endoscopic Vessel Harvesting is expected to increase, helping the market grow.
The United States Holds the Largest Share of the Market
In the United States (US), Cardiovascular disease (CVD), listed as the underlying cause of death, accounted for 840,678 deaths in the US in 2016, as per American Heart Association, making it the leading cause of death in the US. Coronary heart disease accounted for approximately 13% of deaths in the US in 2016, causing 363,452 deaths. This huge burden has increased the demand for effective cardiovascular treatments.
The US having a well-structured healthcare system attracts the global players, and hence enjoys the presence of almost all of them. Hence high demand is met by the presence of global players, which is helping the growth of the market in this region
The majority of the Endoscopic Vessel Harvesting instruments and systems are being manufactured by the global key players. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the market grow.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support